Healthcare & Life Sciences

Nectin Therapeutics

Nectin Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series A, 1 tracked investor.

series-a
series-a
Stage
1
Investors

About Nectin Therapeutics

Based in Israel, Nectin Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Nectin Therapeutics is developing immunotherapeutic biologic drugs that target receptors in the nectin protein family to treat solid and hematological cancers. The company is advancing a pipeline of targeted antibodies designed to block tumor inhibitory pathways and enable immune cells to eliminate cancer cells.

Explore Nectin Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in Israel